Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis

被引:13
|
作者
Navaneethan, Udayakumar [1 ]
Venkatesh, Preethi G. K. [1 ]
Lashner, Bret A. [1 ]
Remzi, Feza H.
Shen, Bo [1 ]
Kiran, Ravi P.
机构
[1] Cleveland Clin, Inst Digest Dis, Dept Gastroenterol, Cleveland, OH 44106 USA
来源
JOURNAL OF CROHNS & COLITIS | 2012年 / 6卷 / 08期
关键词
Primary sclerosing cholangitis; Ulcerative colitis; Inflammatory bowel disease; Liver transplantation; Dysplasia; INFLAMMATORY-BOWEL-DISEASE; NATURAL-HISTORY; LOW-GRADE; PSC-IBD; DYSPLASIA; CANCER; RISK; CLASSIFICATION; SURVEILLANCE;
D O I
10.1016/j.crohns.2012.01.012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aim: Surveillance for colon cancer is recommended in patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC). It is unclear whether characteristics of colon neoplasia have changed over time. The aim of the study was to examine the temporal trends in colon neoplasia in patients with PSC and UC. Methods: A total of 167 patients followed up at our institution between 1985 and 2011, 55 of these with neoplasia detected on colonoscopic biopsy were identified. Characteristics of patients with colon neoplasia in PSC UC were studied for two different time periods: 1985-1998 (early cohort) compared to 1999-2011 (recent cohort). Results: The median age at diagnosis of colon neoplasms was 53 years (median IQR, 43-63). The baseline characteristics were similar in both cohorts. The colonic neoplasms that developed in PSC UC patients were spread throughout the colon on colonoscopy, while there was predominant right sided distribution on colectomy in both cohorts. (81.7% vs. 18.3%, p<0.001) Compared to the recent cohort, both the PSC (17 vs. 11 years, p=0.02) and UC duration (20 vs. 12 years, p=0.02) were longer in the early cohort. There were no differences in the grades and stages of cancer diagnosis. In addition, no differences in transplant-free survival or UC characteristics were revealed. Conclusions: With annual colonoscopic surveillance, dysplasia and cancer in patients with a combined diagnosis of PSC//UC is being diagnosed in patients with a shorter duration of these conditions. The nature and the location of neoplasia have, however, not changed. (c) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:845 / 851
页数:7
相关论文
共 50 条
  • [31] Presence of ileitis is a risk factor for dysplasia in patients with ulcerative colitis as well as in patients with primary sclerosing cholangitis with ulcerative colitis
    Nalluri, Murali K.
    Raghuwanshi, Naishadh N.
    Smith, Timothy M.
    Swaroop, Prabhakar P.
    GASTROENTEROLOGY, 2007, 132 (04) : A661 - A661
  • [32] Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients
    Kumagai, Junichiro
    Taide, Takashi
    Ogasawara, Sadahisa
    Nakagawa, Tomoo
    Lino, Yotaro
    Shingyoji, Ayako
    Ishikawa, Kentaro
    Akizue, Naoki
    Yamato, Mutsumi
    Takahashi, Koji
    Ohta, Yuki
    Hamanaka, Shinsaku
    Okimoto, Kenichiro
    Nakamura, Masato
    Ohyama, Hiroshi
    Saito, Keiko
    Kusakabe, Yuko
    Maruoka, Daisuke
    Yasui, Shin
    Matsumura, Tomoaki
    Sugiyama, Harutoshi
    Sakai, Yuji
    Mikata, Rintaro
    Arai, Makoto
    Katsuno, Tatsuro
    Tsuyuguchi, Toshio
    Kato, Naoya
    PLOS ONE, 2018, 13 (12):
  • [33] Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
    Bajer, Lukas
    Kverka, Miloslav
    Kostovcik, Martin
    Macinga, Peter
    Dvorak, Jiri
    Stehlikova, Zuzana
    Brezina, Jan
    Wohl, Pavel
    Spicak, Julius
    Drastich, Pavel
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (25) : 4548 - 4558
  • [34] Restorative Surgery in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis Following a Colectomy
    Nordenvall, Caroline
    Olen, Ola
    Nilsson, Per Johan
    Ekbom, Anders
    Bottai, Matteo
    Myrelid, Par
    Bergquist, Annika
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (03) : 624 - 632
  • [35] Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis
    Lundberg Bave, Aiva
    Olen, Ola
    Soederling, Jonas
    Ludvigsson, Jonas F.
    Bergquist, Annika
    Nordenvall, Caroline
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (05) : 471 - 481
  • [36] Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis
    Kevans, D.
    Tyler, A. D.
    Holm, K.
    Jorgensen, K. K.
    Vatn, M. H.
    Karlsen, T. H.
    Kaplan, G. G.
    Eksteen, B.
    Gevers, D.
    Hov, J. R.
    Silverberg, M. S.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (03): : 330 - 337
  • [37] Letter: ulcerative colitis in patients transplanted for primary sclerosing cholangitis - authors' reply
    Navaneethan, U.
    Venkatesh, P. G. K.
    Kiran, R. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (03) : 297 - 297
  • [38] Characterization of the Intestinal Microbiome in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis
    Kevans, David
    Tyler, Andrea D.
    Holm, Kristian
    Jorgensen, Kristin K.
    Vatn, Morten H.
    Karlsen, Tom H.
    Gevers, Dirk
    Hov, Johannes R.
    Silverberg, Mark S.
    HEPATOLOGY, 2013, 58 : 251A - 251A
  • [39] Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
    Lukas Bajer
    Miloslav Kverka
    Martin Kostovcik
    Peter Macinga
    Jiri Dvorak
    Zuzana Stehlikova
    Jan Brezina
    Pavel Wohl
    Julius Spicak
    Pavel Drastich
    World Journal of Gastroenterology, 2017, (25) : 4548 - 4558
  • [40] Liver outcomes following proctocolectomy in patients with primary sclerosing cholangitis and ulcerative colitis
    Ryan, Thomas
    Segal, Jonathan P.
    FRONTLINE GASTROENTEROLOGY, 2024, 15 (04) : 314 - 320